Protein kinase C (PKC) family in cancer progression

J Koivunen, V Aaltonen, J Peltonen - Cancer letters, 2006 - Elsevier
PKC family consist of a number of serine-threonine kinases which are divided into three
groups based on their activating factors. PKCs have been linked to carcinogenesis since …

Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy

Y Wang, P Ji, J Liu, RR Broaddus, F Xue, W Zhang - Molecular cancer, 2009 - Springer
In eukaryotic cells, control mechanisms have developed that restrain cell-cycle transitions in
response to stress. These regulatory pathways are termed cell-cycle checkpoints. The G 2/M …

Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress

SJH Arlander, AK Eapen, BT Vroman… - Journal of Biological …, 2003 - ASBMB
DNA damage and replication stress activate the Chk1 signaling pathway, which blocks S
phase progression, stabilizes stalled replication forks, and participates in G 2 arrest. In this …

Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation

G Bertrand, M Maalouf, A Boivin… - Stem Cell Reviews and …, 2014 - Springer
Although promising new radiation therapy techniques such as hadrontherapy are currently
being evaluated in the treatment of head and neck malignancies, local control of head and …

Enhanced Tumor Cell Radiosensitivity and Abrogation of G2 and S Phase Arrest by the Hsp90 Inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin

EEA Bull, H Dote, KJ Brady, WE Burgan, DJ Carter… - Clinical cancer …, 2004 - AACR
Purpose: Because of the potential for affecting multiple signaling pathways, inhibition of
Hsp90 may provide a strategy for enhancing tumor cell radiosensitivity. Therefore, we have …

Genealogy, expression, and molecular mechanisms in apoptosis

Z Dlamini, Z Mbita, M Zungu - Pharmacology & therapeutics, 2004 - Elsevier
Apoptosis, known as programmed cell death, is a conserved, gene-directed mechanism for
the elimination of unnecessary or unwanted cells from an organism. A retrospective look at …

The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation

AY Ali, MR Abedini, BK Tsang - Oncogene, 2012 - nature.com
Abstract Cisplatin (CDDP: cis-diamminedichloroplatinum) resistance is a major hurdle in the
treatment of human ovarian cancer (OVCA). A better understanding of the mechanisms of …

Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review

MA Morgan, LA Parsels, J Maybaum… - Clinical Cancer Research, 2008 - AACR
In the last three decades, gemcitabine has progressed from the status of a laboratory
cytotoxic drug to a standard clinical chemotherapeutic agent and a potent radiation …

Is low-dose hyper-radiosensitivity a measure of G2-phase cell radiosensitivity?

B Marples - Cancer and Metastasis Reviews, 2004 - Springer
Low-dose hyper-radiosensitivity describes a phenomenon by which cells die from excessive
sensitivity to small single doses of ionizing radiation below∼ 20–30 cGy. This review …

Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer

A Sánchez-Castillo, E Heylen, J Hounjet… - British Journal of …, 2024 - nature.com
Background Lung cancer is the most lethal cancer, and 85% of cases are classified as non-
small cell lung cancer (NSCLC). Metabolic rewiring is a cancer hallmark that causes …